Cargando…

Correction to: Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays

Detalles Bibliográficos
Autores principales:	Wintgens, Jan P., Wichert, Sven P., Popovic, Luksa, Rossner, Moritz J., Wehr, Michael C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6744376/ https://www.ncbi.nlm.nih.gov/pubmed/31377842 http://dx.doi.org/10.1007/s00018-019-03244-9

Ejemplares similares

Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays
por: Wintgens, Jan P., et al.
Publicado: (2019)

Multiplexed profiling of GPCR activities by combining split TEV assays and EXT-based barcoded readouts
por: Galinski, Sabrina, et al.
Publicado: (2018)

Analysis of transient phosphorylation-dependent protein-protein interactions in living mammalian cells using split-TEV
por: Wehr, Michael C, et al.
Publicado: (2008)

Improved Split TEV GPCR β-arrestin-2 Recruitment Assays via Systematic Analysis of Signal Peptide and β-arrestin Binding Motif Variants
por: Wu, Yuxin, et al.
Publicado: (2022)

Pathway sensor-based functional genomics screening identifies modulators of neuronal activity
por: Herholt, Alexander, et al.
Publicado: (2018)

Disturbed Clockwork Resetting in Sharp-1 and Sharp-2 Single and Double Mutant Mice
por: Rossner, Moritz J., et al.
Publicado: (2008)

Spironolactone is an antagonist of NRG1‐ERBB4 signaling and schizophrenia‐relevant endophenotypes in mice
por: Wehr, Michael C, et al.
Publicado: (2017)

Split-Cre Complementation Indicates Coincident Activity of Different Genes In Vivo
por: Hirrlinger, Johannes, et al.
Publicado: (2009)

Mice Lacking the Circadian Modulators SHARP1 and SHARP2 Display Altered Sleep and Mixed State Endophenotypes of Psychiatric Disorders
por: Baier, Paul C., et al.
Publicado: (2014)

Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53
por: Herold, Sabine, et al.
Publicado: (2015)

The multispecific thyroid hormone transporter OATP1C1 mediates cell-specific sulforhodamine 101-labeling of hippocampal astrocytes
por: Schnell, Christian, et al.
Publicado: (2013)

Tyrosine kinase inhibitors in osteosarcoma: Adapting treatment strategiesa
por: Assi, Ahmad, et al.
Publicado: (2023)

Serine-Threonine Kinases Encoded by Split hipA Homologs Inhibit Tryptophanyl-tRNA Synthetase
por: Vang Nielsen, Stine, et al.
Publicado: (2019)

Cellular Assays for High-Throughput Screening for Modulators of Trk Receptor Tyrosine Kinases
por: Wang, Jun, et al.
Publicado: (2008)

Salt-inducible kinases regulate growth through the Hippo signalling pathway in Drosophila
por: Wehr, Michael C., et al.
Publicado: (2013)

Analysis of intracellular tyrosine phosphorylation in circulating neutrophils as a rapid assay for the in vivo effect of oral tyrosine kinase inhibitors
por: Futosi, Krisztina, et al.
Publicado: (2023)

Experimental and Computational Evaluation of Chloranilic Acid as an Universal Chromogenic Reagent for the Development of a Novel 96-Microwell Spectrophotometric Assay for Tyrosine Kinase Inhibitors
por: Darwish, Ibrahim A., et al.
Publicado: (2021)

Genetically encoded live-cell sensor for tyrosinated microtubules
por: Kesarwani, Shubham, et al.
Publicado: (2020)

Bruton’s tyrosine kinase is at the crossroads of metabolic adaptation in primary malignant human lymphocytes
por: Sharif-Askari, Bahram, et al.
Publicado: (2019)

Tyrosine Kinases in Cancer
por: Blau, Olga, et al.
Publicado: (2015)

Targeted mass-spectrometry-based assays enable multiplex quantification of receptor tyrosine kinase, MAP kinase, and AKT signaling
por: Whiteaker, Jeffrey R., et al.
Publicado: (2021)

Application of a Substrate-Mediated Selection with c-Src Tyrosine Kinase to a DNA-Encoded Chemical Library
por: Kim, Dongwook, et al.
Publicado: (2019)

Tyrosine kinase signalling in breast cancer: ErbB family receptor tyrosine kinases
por: Stern, David F
Publicado: (2000)

Targeting Spleen Tyrosine Kinase-Bruton's Tyrosine Kinase Axis for Immunologically Mediated Glomerulonephritis
por: Chen, Jin-Shuen, et al.
Publicado: (2014)

Pyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn
por: Li, Chuanzhou, et al.
Publicado: (2018)

Rescue of Comorbid Behavioral and Metabolic Phenotypes of Arrhythmic Mice by Restoring Circadian Cry1/2 Expression in the Suprachiasmatic Nucleus
por: Hühne-Landgraf, Anisja, et al.
Publicado: (2023)

Tyrosine Kinases in Autoimmune and Inflammatory Skin Diseases
por: Szilveszter, Kata P., et al.
Publicado: (2019)

Combining H-Adaptivity with the Element Splitting Method for Crack Simulation in Large Structures
por: Song, Shi, et al.
Publicado: (2021)

BY-kinases: Protein tyrosine kinases like no other
por: Hajredini, Fatlum, et al.
Publicado: (2022)

Tyrosine kinases in rheumatoid arthritis
por: Okamoto, Hiroshi, et al.
Publicado: (2011)

Tyrosine Kinase Inhibitors and Interferon
por: Dimou, Maria, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors for the Elderly
por: Hohenforst-Schmidt, Wolfgang, et al.
Publicado: (2016)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2016)

Tyrosine Kinase Inhibitors and Pregnancy
por: Abruzzese, Elisabetta, et al.
Publicado: (2014)

Receptor tyrosine kinases in carcinogenesis
por: Zhang, Xiao-Ying, et al.
Publicado: (2020)

Tyrosine Kinase Receptors in Oncology
por: Esteban-Villarrubia, Jorge, et al.
Publicado: (2020)

Nanomedicine of tyrosine kinase inhibitors
por: Smidova, Veronika, et al.
Publicado: (2021)

Adult diffuse gliomas produce mRNA transcripts encoding EGFR isoforms lacking a tyrosine kinase domain
por: GUILLAUDEAU, ANGÉLIQUE, et al.
Publicado: (2011)

The sum of gains and losses of genes encoding the protein tyrosine kinase targets predicts response to multi-kinase inhibitor treatment: Characterization, validation, and prognostic value
por: Jiang, Xiaojun, et al.
Publicado: (2015)

Evaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer
por: Labots, Mariette, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_279gabbpb5jmibmjl5jmc271p1